Neurogenic stunned myocardium

Current Neurology and Neuroscience Reports

Volumn 9, Issue 6, 2009, Pages 486-491

  Nguyen, Hoang ^b   Zaroff, Jonathan G ^a  

^a Kaiser San Francisco Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE ISOENZYME; DOBUTAMINE; HEART ENZYME; MILRINONE; NIMODIPINE; PHENTOLAMINE; PHENYLEPHRINE; PLACEBO; PROPRANOLOL; TROPONIN I;

ANEURYSM CLIP; BRAIN INJURY; BRAIN VASOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; DRUG MECHANISM; DRUG MEGADOSE; ECG ABNORMALITY; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; INFLAMMATION; NEUROANATOMY; NEUROGENIC STUNNED MYOCARDIUM; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; QT INTERVAL; QT PROLONGATION; REVIEW; SUBARACHNOID HEMORRHAGE;

ANIMALS; BRAIN INJURIES; HUMANS; MYOCARDIAL STUNNING;

EID: 70350142704     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0071-0     Document Type: Review

References (45)

1. Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
2. Silver FL, Norris JW, Lewis AJ, Hachinski VC: Early mortality following stroke: A prospective review. Stroke 1984, 15:492-496.
3. Hartmann A, Rundek T, Mast H, et al.: Mortality and causes of death after first ischemic stroke: The Northern Manhattan Stroke Study. Neurology 2001, 57:2000-2005.
4. Natelson BH, Chang Q: Sudden death. A neurocardiologic phenomenon. Neurol Clin 1993, 11:293-308.
5. Cheung RT, Hachinski V: The insula and cerebrogenic sudden death. Arch Neurol 2000, 57:1685-1688.
6. Burch GE, Meyers R, Abildskov JA: A new electrocardiographic pattern observed in cerebrovascular accidents. Circulation 1954, 9:719-723.
7. Cheung RT, Hachinski V: Cardiac effects of stroke. Curr Treat Options Cardiovasc Med 2004, 6:199-207.
8. Sakr YL, Lim N, Amaral AC, et al.: Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol 2004, 96:369-373.
9. Di Pasquale G, Pinelli G, Andreoli A, et al.: Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol 1987, 59:596-600.
10. Sommargren CE, Zaroff JG, Banki N, Drew BJ: Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J Electrocardiol 2002, 35(Suppl): 257-262.
11. Banki N, Kopelnik A, Tung P, et al.: Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg 2006, 105:15-20.
12. Andreoli A, di Pasquale G, Pinelli G, et al.: Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. Stroke 1987, 18:558-564.
13. Goldstein DS: The electrocaRdiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 1979, 10:253-259.
14. Rem JA, Hachinski VC, Boughner DR, Barnett HJ: Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke 1985, 16:950-956.
15. Machado C, Baga JJ, Kawasaki R, et al.: Torsade de pointes as a complication of subarachnoid hemorrhage: A critical reappraisal. J Electrocardiol 1997, 30:31-37.
16. van den Bergh WM, Algra A, Rinkel GJ: Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke 2004, 35:644-648.
17. Frangiskakis MJ, Hravnak M, Crago EA, et al.: Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care 2009, 10:287-294.
18. Deibert E, Barzilai B, Braverman AC, et al.: Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg 2003, 98:741-746.
19. Parekh N, Venkatesh B, Cross D, et al.: Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000, 36:1328-1335.
20. Tung P, Kopelnik A, Banki N, et al.: Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004, 35:548-551.
21. Tung PP, Olmsted E, Kopelnik A, et al.: Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 2005, 36:1567-1569.
22. Naidech AM, Kreiter KT, Janjua N, et al.: Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005, 112:2851-2856.
23. McGirt MJ, Blessing R, Nimjee SM, et al.: Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004, 54:1369-1373; discussion 1373-1374.
24. Yarlagadda S, Rajendran P, Miss JC, et al.: Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocrit Care 2006, 5:102-107.
25. Kopelnik A, Fisher L, Miss JC, et al.: Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care 2005, 3:132-138.
26. Kawahara E, Ikeda S, Miyahara Y, Kohno S: Role of autonomic nervous dysfunction in electrocardio-graphic abnormalities and cardiac injury in patients with acute subarachnoid hemorrhage. Circ J 2003, 67:753-756.
27. Tracey KJ: The inflammatory reflex. Nature 2002, 420:853-859.
28. Tsai FC, Marelli D, Bresson J, et al.: Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant 2002, 21:623-628.
29. Yamani MH, Starling RC, Cook DJ, et al.: Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient. Circulation 2003, 108:1724-1728.
30. Yamani MH, Cook DJ, Tuzcu EM, et al.: Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am J Transplant 2004, 4:1097-1102.
31. Mathiesen T, Edner G, Ulfarsson E, Andersson B: Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997, 87:215-220.
32. Kikuchi T, Okuda Y, Kaito N, Abe T: Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 1995, 17:106-108.
33. Kwon KY, Jeon BC: Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci 2001, 16:774-780.
34. Hirashima Y, Nakamura S, Endo S, et al.: Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 1997, 22:1249-1255.
35. Gruber A, Rossler K, Graninger W, et al.: Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000, 12:297-306.
36. Kopelnik A, Zaroff JG: Neurocardiogenic injury in neurovascular disorders. Crit Care Clin 2006, 22:733-752; abstract ix-x.
37. Banki NM, Kopelnik A, Dae MW, et al.: Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 2005, 112:3314-3319.
38. Naidech A, Du Y, Kreiter KT, et al.: Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery 2005, 56:21-6l; discussion 6-7.
39. Neil-Dwyer G, Walter P, Cruickshank J, et al.: Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J 1978, 2:990-992.
40. van der Bilt IA, Hasan D, Vandertop WP, et al.: Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: A meta-analysis. Neurology 2009, 72:635-642.
41. Coghlan LA, Hindman BJ, Bayman EO, et al.: Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage: Findings from the intraoperative hypothermia aneurysm surgery trial. Stroke 2009, 40: 412-418.
42. Dhamoon MS, Sciacca RR, Rundek T, et al.: Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study. Neurology 2006, 66:641-646.
43. Laowattana S, Zeger SL, Lima JA, et al.: Left insular stroke is associated with adverse cardiac outcome. Neurology 2006, 66: 477-83; discussion 63.
44. Miss JC, Kopelnik A, Fisher LA, et al.: Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy. Neurosurgery 2004, 55:1244-1250; discussion 50-51.
45. Mashaly HA, Provencio JJ: Inflammation as a link between brain injury and heart damage: The model of subarachnoid hemorrhage. Cleve Clin J Med 2008, 75: 26-30.